Evidence map›Paper›PMID 38746475›Full record

ArticlebioRxiv : the preprint server for biology2024

In vitro heterochronic parabiosis identifies pigment epithelium-derived factor as a systemic mediator of rejuvenation by young blood.

Xizhe Wang, Cagdas Tazearslan, Seungsoo Kim, Qinghua Guo, Daniela Contreras, Jiping Yang, Adam D Hudgins, Yousin Suh

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xizhe WangDepartment of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.
Cagdas TazearslanDepartment of Genetics, Albert Einstein College of Medicine, Bronx, NY.
Seungsoo KimDepartment of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.ORCID 0000-0002-6602-633X
Qinghua GuoDepartment of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.
Daniela ContrerasDepartment of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.
Jiping YangDepartment of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.
Adam D HudginsDepartment of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.ORCID 0000-0002-2737-6839
Yousin SuhDepartment of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.

Funding

From in vivo to in vitro heterochronic parabiosis to identify geronic factorsR01AG057433 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RANDO, THOMAS A., SUH, YOUSIN · 2017 to 2020
$2.1M
NIA NIH HHS R01 AG057433
6 · The paper itself

Abstract

Several decades of heterochronic parabiosis (HCPB) studies have demonstrated the restorative impact of young blood, and deleterious influence of aged blood, on physiological function and homeostasis across tissues, although few of the factors responsible for these observations have been identified. Here we develop an in vitro HCPB system to identify these circulating factors, using replicative lifespan (RLS) of primary human fibroblasts as an endpoint of cellular health. We find that RLS is inversely correlated with serum donor age and sensitive to the presence or absence of specific serum components. Through in vitro HCPB, we identify the secreted protein pigment epithelium-derived factor (PEDF) as a circulating factor that extends RLS of primary human fibroblasts and declines with age in mammals. Systemic administration of PEDF to aged mice reverses age-related functional decline and pathology across several tissues, improving cognitive function and reducing hepatic fibrosis and renal lipid accumulation. Together, our data supports PEDF as a systemic mediator of the effect of young blood on organismal health and homeostasis and establishes our in vitro HCPB system as a valuable screening platform for the identification of candidate circulating factors involved in aging and rejuvenation.

Identifiers

PMID38746475
PMCPMC11092633

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.